Back to top

Aggressive Growth

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

PAREXEL International Corp (PRXL - Snapshot Report) is coming off of a record-setting year and raised its outlook. Estimates are on the rise and have shares at attractive valuations.

Company Description

PAREXEL International is a pharmaceutical services company, providing research, consulting, and medical communications services.

A Record-Setting Year

On Aug 9 PAREXEL reported its fourth-quarter results for fiscal 2011 that showed a 5.2% increase in revenue, to $311 million. Annual revenues hit a company record of $1.2 billion. On the year the backlog swelled 29%, to $3.4 billion.

Earnings per share came in at $0.10, 4 cents higher than the Zacks Consensus Estimate. The company has beaten estimates in 7 of the last 8 quarters.

Optimism Rising

PAREXEL raised its outlook for the coming year as well. Analysts followed suit and those upward estimate revisions gave PRXL a Zacks #1 Rank (Strong Buy).

The Zacks Consensus Estimate for this fiscal year is up 6 cents, to $1.11 in the past 2 months. Next years estimates are averaging $1.57. That puts projected earnings growth at 17% and 42%, respectively.

Valuations

Shares of PRXL are going for roughly 18 times forward estimates, which puts the PEG ratio at 1.1. The price to sales is at 0.8 times and the stock is going for 2.2 times book value.

The Chart

PRXL has been in a fairly wide trading range lately, but with the outlook improving the stock could break out any day. When an appetite for risk returns to the market, investors may flock to PAREXEL.

PAREXEL International Corp - ticker PRXL>
 
 
<P ALIGN=

Bill Wilton is the Aggressive Growth Stock Strategist for Zacks.com. He is also the Editor in charge of the Zacks Small Cap Trader service

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
BITAUTO HOLD BITA 35.33 +14.82%
ANI PHARMACE ANIP 24.79 +14.66%
E-HOUSE CHIN EJ 10.99 +9.24%
CANADIAN SOL CSIQ 26.97 +7.15%
INTL CONS AI ICAGY 33.30 +5.38%